How can the pharma industry balance rapid digital transformation with caution and consideration?

How can the pharmaceutical industry ensure cell and gene therapies are adopted by payers?

How is the pharmaceutical industry moving from business continuity back to growth?

While the pharmaceutical industry responded swiftly and effectively to threat of COVID-19, they cannot deny their unpreparedness.

Words by Isabel O’Brien After years of tough negotiations, the ongoing Brexit saga has all but concluded, and the UK has left the...

Words by Louise Rogers When two stars collide, the result is often explosive; the aftermath creating a light visible on Earth thousands,...

Words by Isabel O’Brien As Zoom stock prices peak, meme culture becomes cross-generational, and our Wi-Fi routers long wistfully for the...

Words by Michaila Byrne Not only does the very idea of a medicine being created by patients undermine our abiding belief in the...

Words by James Coker There has been an increasing focus on the development of precision medicine in the pharmaceutical industry over...

Words by James Coker “The last 10 years have seen enormous growth within the design industry. We now have UX, UI, and service design. And...

Words by James Coker Many of the most transformative innovations are taking place in the developing world on an increasingly regular...

Words by Kirstie Turner Pharma is seeing a host of ground-breaking innovations, with companies developing new technologies that are...

Words by Louise Rogers In the 1985 blockbuster, 17-year-old Californian teenager Marty McFly is accidently sent back to 1955 in the time...

Words by James Coker There’s a general consensus that pharma has not yet put itself in a position to take on the healthcare challenges of...

Words by James Coker “The technology shift in cell and gene therapy is happening in front of our faces, and it’s going to be the biggest...

Words by James Coker That pharma must undergo a reformation, moving to a whole new model of technological innovation, patient centricity,...

Words by Saskia Pronk “We are getting more and more restricted access to HCPs”, warns Hannelore Grams, AbbVie’s Global Director...

Words by Martin Lush, Global Vice President, Pharma Biotech and Medical Devices, NSF International. To prosper in this era of brutal...